CTCX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 16:00):

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging...

Stats
Today's Volume	19 042.00
Average Volume	6 298.00
Market Cap	38.49M
EPS	$0 ( 2024-03-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.310
ATR14	$0.0520 (2.60%)

Carmell Therapeutics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Carmell Therapeutics Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-124 788 (0.00 %)
EPS:	$-1.400

FY	2023
Revenue:	$0
Gross Profit:	$-124 788 (0.00 %)
EPS:	$-1.400

FY	2022
Revenue:	$0
Gross Profit:	$-242 556 (0.00 %)
EPS:	$-0.460

Financial Reports:

No articles found.

Carmell Therapeutics

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.